Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-25 @ 8:09 PM
NCT ID:
NCT01834235
Population Description:
NEO-102 Dose level 1 in combination with Gemcitabine was found to be safe and hence the NEO-102 dose did not need to be de-escalated to Dose level -1.
Study:
NCT01834235
Study Brief:
Results Section:
NCT01834235